Prednisone (Oral)
Treatment for Pyoderma
Typical Dosage: 0.5-2 mg/kg/day, tapered
Effectiveness
80%
Safety Score
38%
Clinical Trials
50
Participants
1K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
38
DangerousModerateSafe
Treatment Details
Dosage Range
0.5-2 mg/kg/day, tapered
Time to Effect
1-2 weeks
Treatment Duration
Initial high dose for weeks, then taper over months
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$500
Side Effect Mgmt:$200
Total Annual:$750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$937.5/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$1,071.43
Cost per Remission
$1,875
Prednisone (Oral) Outcomes
for Pyoderma
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+70%
Remission Rate
+40%
Common Side Effects
Weight gain
+70%
Hyperglycemia
+40%
Hypertension
+30%
Mood changes
+25%
Infections
+15%
Osteoporosis (long-term)
+10%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov